Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Market sentiment signals for Arbutus Biopharma (ABUS): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
4 analysts
Options Flow (P/C)
0.00
More calls — Bullish
Avg Consensus PT
$6
+34.8%
Highest Price Target
$7
+71.6%
Lowest Price Target
$5
+22.5%
Short Interest
14.9%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Nov 14, 2025 | Chardan Capital | Keay Nakae— | +22.5% | $5 → $5 | Maintained | Buy |
| Aug 11, 2025 | Chardan Capital | Keay Nakae— | +22.5% | $5 → $5 | Maintained | Buy |
